Document
IPR2021-00816, No. 2230-264 Exhibit - Ex 2230 EU Q5C (P.T.A.B. Jan. 18, 2022)
Cite Document
IPR2021-00816, No. 2230-264 Exhibit - Ex 2230 EU Q5C (P.T.A.B. Jan. 18, 2022)
+ More Snippets
Document
IPR2021-00816, No. 2228-262 Exhibit - Ex 2228 FDA Guidance for Industry ��� Q1A R2 Stability Testing of New Drug Substances and Products 2003 (P.T.A.B. Jan. 18, 2022)
Cite Document
IPR2021-00816, No. 2228-262 Exhibit - Ex 2228 FDA Guidance for Industry ��� Q1A R2 Stability Testing of New Drug Substances and Products 2003 (P.T.A.B. Jan. 18, 2022)
+ More Snippets
Document
IPR2021-00816, No. 2317-324 Exhibit - Ex 2317 Gallemore 2006 (P.T.A.B. Jan. 18, 2022)
Cite Document
IPR2021-00816, No. 2317-324 Exhibit - Ex 2317 Gallemore 2006 (P.T.A.B. Jan. 18, 2022)
+ More Snippets
Document
IPR2021-00816, No. 2229-263 Exhibit - Ex 2229 Rathore 2011 (P.T.A.B. Jan. 18, 2022)
Cite Document
IPR2021-00816, No. 2229-263 Exhibit - Ex 2229 Rathore 2011 (P.T.A.B. Jan. 18, 2022)
+ More Snippets
Document
IPR2021-00816, No. 2285-294 Exhibit - Ex 2285 Avastin FDA Label (P.T.A.B. Jan. 18, 2022)
Cite Document
IPR2021-00816, No. 2285-294 Exhibit - Ex 2285 Avastin FDA Label (P.T.A.B. Jan. 18, 2022)
+ More Snippets
Document
IPR2021-00816, No. 2081-212 Exhibit - Exhibit 2081 PUBLIC REDACTED VERSION (P.T.A.B. Nov. 19, 2021)
Cite Document
IPR2021-00816, No. 2081-212 Exhibit - Exhibit 2081 PUBLIC REDACTED VERSION (P.T.A.B. Nov. 19, 2021)
+ More Snippets
Document
IPR2021-00816, No. 2074-205 Exhibit - Exhibit 2074 PUBLIC REDACTED VERSION (P.T.A.B. Nov. 19, 2021)
Cite Document
IPR2021-00816, No. 2074-205 Exhibit - Exhibit 2074 PUBLIC REDACTED VERSION (P.T.A.B. Nov. 19, 2021)
+ More Snippets
Document
IPR2021-00816, No. 2062-157 Exhibit - Declaration of Jeffrey Salling (P.T.A.B. Jul. 28, 2021)
Cite Document
IPR2021-00816, No. 2062-157 Exhibit - Declaration of Jeffrey Salling (P.T.A.B. Jul. 28, 2021)
+ More Snippets
Document
IPR2021-00816, No. 2028-128 Exhibit - 2028 (P.T.A.B. Jul. 28, 2021)
Cite Document
IPR2021-00816, No. 2028-128 Exhibit - 2028 (P.T.A.B. Jul. 28, 2021)
+ More Snippets
Document
IPR2021-00816, No. 2056-151 Exhibit - 2056 (P.T.A.B. Jul. 28, 2021)
Cite Document
IPR2021-00816, No. 2056-151 Exhibit - 2056 (P.T.A.B. Jul. 28, 2021)
+ More Snippets
Document
IPR2021-00816, No. 2041-137 Exhibit - 2041 (P.T.A.B. Jul. 28, 2021)
Cite Document
IPR2021-00816, No. 2041-137 Exhibit - 2041 (P.T.A.B. Jul. 28, 2021)
+ More Snippets
Document
IPR2021-00816, No. 2007-107 Exhibit - 2007 (P.T.A.B. Jul. 28, 2021)
Cite Document
IPR2021-00816, No. 2007-107 Exhibit - 2007 (P.T.A.B. Jul. 28, 2021)
+ More Snippets
Document
IPR2021-00816, No. 1242-640 Exhibit - R DeForest McDuff, Ryan C Andrews, and Matt D Brundage, Thinking Economically about Commercial Success, Landslide, 94 1 5 MarApr 2017 (P.T.A.B. ...
Cite Document
IPR2021-00816, No. 1242-640 Exhibit - R DeForest McDuff, Ryan C Andrews, and Matt D Brundage, Thinking Economically about Commercial Success, Landslide, 94 1 5 MarApr 2017 (P.T.A.B. Apr. 15, 2022)
+ More Snippets
Document
IPR2021-00816, No. 1170-603 Exhibit - Curriculum Vitae of Lisa Cameron (P.T.A.B. Apr. 15, 2022)
Cite Document
IPR2021-00816, No. 1170-603 Exhibit - Curriculum Vitae of Lisa Cameron (P.T.A.B. Apr. 15, 2022)
+ More Snippets
Document
IPR2021-00816, No. 1198-647 Exhibit - Excerpt of Research Design Model Specification,��� Reference Manual on Scientific Evidence, 3rd edition, National AcademicsPress, 2011 (P.T.A.B. Apr. ...
Cite Document
IPR2021-00816, No. 1198-647 Exhibit - Excerpt of Research Design Model Specification,��� Reference Manual on Scientific Evidence, 3rd edition, National AcademicsPress, 2011 (P.T.A.B. Apr. 15, 2022)
+ More Snippets